Key result
Diabetes does not compromise procedural success or 1-year mortality in tricuspid TEER.
Why the study?
Diabetes mellitus is common in patients undergoing tricuspid TEER but its impact on procedural success and outcomes was previously unstudied.
Does diabetes mellitus worsen outcomes in patients with symptomatic severe tricuspid regurgitation undergoing transcatheter tricuspid valve repair using the edge-to-edge technique?
Cohort (n=105)
No
Does diabetes mellitus worsen outcomes in patients with symptomatic severe tricuspid regurgitation undergoing transcatheter tricuspid valve repair using the edge-to-edge technique?
Diabetes mellitus does not adversely affect procedural success, in-hospital outcomes, or 1-year mortality and heart failure hospitalization in patients undergoing tricuspid TEER.
Answers are grounded in this paper and cite their sources.
Diabetes was not associated with worse tricuspid TEER outcomes; leaves open confirmation in larger prospective studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Alachkar et al. (2026) conducted a cohort in Symptomatic severe tricuspid regurgitation (n=105). Diabetes mellitus vs. Without diabetes mellitus was evaluated on Procedural success (implantation of at least 1 clip with ≥1-grade reduction in tricuspid regurgitation) (p=0.320). In patients undergoing tricuspid transcatheter edge-to-edge repair, the presence of diabetes mellitus did not impact procedural success or 1-year mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: